Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (SITC)...
Data presented at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer
Xenetic Biosciences: Q3 Earnings Snapshot
Xenetic Biosciences: Q2 Earnings Snapshot
Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer
FRAMINGHAM, MA / ACCESSWIRE / May 10, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...
Xenetic Biosciences: Q1 Earnings Snapshot
Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares began Friday negative, as the company, based out of Framingham, ...
Xenetic Biosciences: Q3 Earnings Snapshot
FRAMINGHAM, MA / ACCESSWIRE / November 10, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...